heart failure
Antagonists of the mineralocorticoid receptor improve morbidity and mortality in patients with severe heart failure.
Antagonists of the <span class="gene" id="21321305-1-19-45">mineralocorticoid receptor</span> improve morbidity and mortality in patients with severe <span class="disease" id="21321305-1-102-115">heart failure</span>.